Release of hyaluronate from eukaryotic cells
- PMID: 2158307
- PMCID: PMC1131262
- DOI: 10.1042/bj2670185
Release of hyaluronate from eukaryotic cells
Abstract
The mechanism of hyaluronate shedding from eukaryotic cell lines was analysed. All cell lines shed identical sizes of hyaluronate as were retained on the surface. They differed in the amount of hyaluronate synthesized and in the proportions of hyaluronate which were released and retained. A method was developed which could discriminate between shedding due to intramolecular degradation and that due to dissociation as intact macromolecules. This method was applied to B6 and SV3T3 cells in order to study the mechanism of hyaluronate release in more detail. The cells were pulse-labelled to form hyaluronate chains with labelled and unlabelled segments, and the sizes of labelled hyaluronate released into the medium during the pulse extension period were determined by gel filtration. B6 cells released identical sizes of hyaluronate at all labelled segment lengths, indicating that no intramolecular degradation occurred. When chain elongation was blocked by periodate-oxidized UDP-glucuronic acid, hyaluronate release was simultaneously inhibited. These results indicated that B6 cells dissociated hyaluronate as an intact macromolecule. In contrast, SV3T3 cells released hyaluronate of varying molecular mass distributions during extension of the labelled segment, suggesting partial degradation. Exogenous hyaluronate added to SV3T3 cultures was also degraded. This degradation could be prevented by the presence of radical scavengers such as superoxide dismutase and tocopherol. Degradation of endogenous hyaluronate could be inhibited by salicylate. These results led to the conclusion that SV3T3 cells released hyaluronate not only by dissociation, but also by radical-induced degradation.
Similar articles
-
Inhibition of hyaluronate synthesis.Biochem J. 1985 Feb 1;225(3):699-705. doi: 10.1042/bj2250699. Biochem J. 1985. PMID: 2983681 Free PMC article.
-
Hyaluronate is synthesized at plasma membranes.Biochem J. 1984 Jun 1;220(2):597-600. doi: 10.1042/bj2200597. Biochem J. 1984. PMID: 6743290 Free PMC article.
-
Synthesis and degradation of hyaluronate by synovia from patients with rheumatoid arthritis.J Rheumatol. 1995 Mar;22(3):400-5. J Rheumatol. 1995. PMID: 7783053
-
Hyaluronate degradation in 3T3 and simian virus-transformed 3T3 cells.J Biol Chem. 1982 May 25;257(10):5821-6. J Biol Chem. 1982. PMID: 6279615
-
The interaction of hyaluronate with the cell surface: the hyaluronate receptor and the core protein.Ciba Found Symp. 1989;143:87-99; discussion 100-6, 281-5. doi: 10.1002/9780470513774.ch6. Ciba Found Symp. 1989. PMID: 2478346 Review.
Cited by
-
Molecular Mechanisms and Therapeutic Role of Intra-Articular Hyaluronic Acid in Osteoarthritis: A Precision Medicine Perspective.J Clin Med. 2025 Apr 8;14(8):2547. doi: 10.3390/jcm14082547. J Clin Med. 2025. PMID: 40283379 Free PMC article. Review.
-
Synthesis and shedding of hyaluronan from plasma membranes of human fibroblasts and metastatic and non-metastatic melanoma cells.Biochem J. 1999 Oct 1;343 Pt 1(Pt 1):71-5. Biochem J. 1999. PMID: 10493913 Free PMC article.
-
CD44 in rheumatoid arthritis.Arthritis Res Ther. 2003;5(3):105-15. doi: 10.1186/ar746. Epub 2003 Feb 28. Arthritis Res Ther. 2003. PMID: 12723975 Free PMC article. Review.
-
Biosynthesis of hyaluronan: direction of chain elongation.Biochem J. 2006 Sep 15;398(3):469-73. doi: 10.1042/BJ20060431. Biochem J. 2006. PMID: 16719838 Free PMC article.
-
Hyaluronic Acid: Molecular Mechanisms and Therapeutic Trajectory.Front Vet Sci. 2019 Jun 25;6:192. doi: 10.3389/fvets.2019.00192. eCollection 2019. Front Vet Sci. 2019. PMID: 31294035 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources